Support from the Michael J. Fox Foundation has reinforced Aleva’s mission
Support from the Michael J. Fox Foundation has reinforced Aleva’s mission
Through its research funding and endorsement, the Michael J. Fox Foundation has played a key role in advancing Aleva’s work in Parkinson’s therapy. The collaboration reflects a shared focus on applying scientific rigour and innovative engineering to improve clinical outcomes in neurostimulation.
Through its research funding and endorsement, the Michael J. Fox Foundation has played a key role in advancing Aleva’s work in Parkinson’s therapy. The collaboration reflects a shared focus on applying scientific rigour and innovative engineering to improve clinical outcomes in neurostimulation.
Context
Context
The collaboration began through a competitive research grant aimed at advancing next-generation neurostimulation systems for movement disorders. By funding Aleva’s clinical research and technology refinement, the Foundation helped accelerate the transition from experimental design to patient-ready therapy — aligning both organisations around the shared goal of better quality of life for people living with Parkinson’s.
The collaboration began through a competitive research grant aimed at advancing next-generation neurostimulation systems for movement disorders. By funding Aleva’s clinical research and technology refinement, the Foundation helped accelerate the transition from experimental design to patient-ready therapy — aligning both organisations around the shared goal of better quality of life for people living with Parkinson’s.
The collaboration began through a competitive research grant aimed at advancing next-generation neurostimulation systems for movement disorders. By funding Aleva’s clinical research and technology refinement, the Foundation helped accelerate the transition from experimental design to patient-ready therapy — aligning both organisations around the shared goal of better quality of life for people living with Parkinson’s.
SHARED ENDEAVOURS
SHARED ENDEAVOURS
Research Grant & Scientific Endorsement
Research Grant & Scientific Endorsement
A partnership grounded in evidence, innovation, and a shared commitment to advancing scientific solutions for neurological disease.
The Michael J. Fox Foundation Overview
The Michael J. Fox Foundation for Parkinson’s Research is the world’s largest non-profit funder of Parkinson’s research, founded in 2000 by actor and advocate Michael J. Fox. MJFF supports scientific excellence across academia and industry to accelerate breakthroughs in diagnosis, treatment, and ultimately a cure for Parkinson’s disease.
Partnership Highlights
Through the Foundation’s support, Aleva advanced the validation of its directSTIM system as a therapeutic alternative to medication-based treatment. The collaboration fostered data-driven insights into symptom reduction and programming efficiency, contributing to Aleva’s broader clinical strategy and visibility within the global Parkinson’s research community.
The Michael J. Fox Foundation Overview
The Michael J. Fox Foundation for Parkinson’s Research is the world’s largest non-profit funder of Parkinson’s research, founded in 2000 by actor and advocate Michael J. Fox. MJFF supports scientific excellence across academia and industry to accelerate breakthroughs in diagnosis, treatment, and ultimately a cure for Parkinson’s disease.
Partnership Highlights
Through the Foundation’s support, Aleva advanced the validation of its directSTIM system as a therapeutic alternative to medication-based treatment. The collaboration fostered data-driven insights into symptom reduction and programming efficiency, contributing to Aleva’s broader clinical strategy and visibility within the global Parkinson’s research community.
“Acceptance doesn’t mean resignation”
“Acceptance doesn’t mean resignation”
— Michael J. Fox
— Michael J. Fox
“Acceptance doesn’t mean resignation”
— Michael J. Fox
Impact & Shared Achievements
The partnership has strengthened Aleva’s scientific credibility and broadened the evidence base supporting directional DBS therapy. By combining Aleva’s engineering precision with the Foundation’s mission-driven support, both organisations have advanced the pursuit of safer, more effective treatments for Parkinson’s disease.
Impact & Shared Achievements
The partnership has strengthened Aleva’s scientific credibility and broadened the evidence base supporting directional DBS therapy. By combining Aleva’s engineering precision with the Foundation’s mission-driven support, both organisations have advanced the pursuit of safer, more effective treatments for Parkinson’s disease.